Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
green decrease » greater decrease (Expand Search), teer decrease (Expand Search), greatest decrease (Expand Search)
Showing 1,861 - 1,880 results of 21,342 for search '(( significant ((green decrease) OR (mean decrease)) ) OR ( significant decrease decrease ))', query time: 0.43s Refine Results
  1. 1861
    Pupal duration of 3<sup>rd</sup> instar and 5<sup>th</sup> instar larvae of RPW after feeding on different dsRNAs.

    Pupal duration of 3<sup>rd</sup> instar and 5<sup>th</sup> instar larvae of RPW after feeding on different dsRNAs. by Muhammad Naeem Sattar (19828497)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 1862
    Adult emergence of 3<sup>rd</sup> instar and 5<sup>th</sup> instar of RPW after feeding on different dsRNAs.

    Adult emergence of 3<sup>rd</sup> instar and 5<sup>th</sup> instar of RPW after feeding on different dsRNAs. by Muhammad Naeem Sattar (19828497)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 1863
    Stable incorporation of p53 lentiplasmids is detectible and does not impact cellular growth rates.

    Stable incorporation of p53 lentiplasmids is detectible and does not impact cellular growth rates. by Nathaniel C. Holcomb (22793595)

    Published 2025
    Save to List
    Saved in:
  4. 1864
    Differences in total Tau and p-Tau Thr231 following maternal Pg-OMV exposure.

    Differences in total Tau and p-Tau Thr231 following maternal Pg-OMV exposure. by Adrienne J. Bradley (20861948)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1865
    RT-qPCR evaluation of MYD88, NLRP3, and NFκβ in GA 18.5 pup brains.

    RT-qPCR evaluation of MYD88, NLRP3, and NFκβ in GA 18.5 pup brains. by Adrienne J. Bradley (20861948)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1866
    Demographic characteristics of study participants.

    Demographic characteristics of study participants. by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1867
    Proportion of first-time testers by key population group.

    Proportion of first-time testers by key population group. by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1868
    Comparative cost analysis of HCVST and PL-HCVT models (in US$).

    Comparative cost analysis of HCVST and PL-HCVT models (in US$). by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1869
    Incremental costs per month for different HCV testing models.

    Incremental costs per month for different HCV testing models. by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1870
    Comparative costs of HCVST and PL-HCVT models in sensitivity analysis (in US$).

    Comparative costs of HCVST and PL-HCVT models in sensitivity analysis (in US$). by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1871
    HCV positivity rate by key population group opting for HCVST and standard HCVT.

    HCV positivity rate by key population group opting for HCVST and standard HCVT. by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1872
    Proportion of first-time HCV testers by testing model.

    Proportion of first-time HCV testers by testing model. by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1873
    MTT experiment shows that the seven MUT plasmids of NANOG protein can significantly inhibit the proliferation of colon cancer stem cells.

    MTT experiment shows that the seven MUT plasmids of NANOG protein can significantly inhibit the proliferation of colon cancer stem cells. by Yin Tian (181303)

    Published 2025
    Save to List
    Saved in:
  14. 1874
    Insulin-free survival in patients with and without FHD.

    Insulin-free survival in patients with and without FHD. by Clemens Plattner (21567706)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1875
    Event-free survival analysis of microvascular outcome.

    Event-free survival analysis of microvascular outcome. by Clemens Plattner (21567706)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1876
    Event-free survival analysis of macrovascular outcome.

    Event-free survival analysis of macrovascular outcome. by Clemens Plattner (21567706)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1877
    Cascade of care by HCV testing model.

    Cascade of care by HCV testing model. by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1878
    Factors associated with first-time HCV testing.

    Factors associated with first-time HCV testing. by Bao Vu Ngoc (14551955)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1879
    Clinical characteristics.

    Clinical characteristics. by Clemens Plattner (21567706)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1880
    Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples.

    Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: